GEMIGNANI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 12.739
AS - Asia 5.430
EU - Europa 4.249
SA - Sud America 792
AF - Africa 186
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.429
Nazione #
US - Stati Uniti d'America 12.469
SG - Singapore 1.786
IT - Italia 1.427
CN - Cina 1.422
HK - Hong Kong 902
BR - Brasile 671
SE - Svezia 575
DE - Germania 574
VN - Vietnam 488
BG - Bulgaria 339
GB - Regno Unito 256
FI - Finlandia 242
TR - Turchia 237
FR - Francia 216
CA - Canada 200
RU - Federazione Russa 181
IN - India 117
UA - Ucraina 111
KR - Corea 105
JP - Giappone 97
CI - Costa d'Avorio 62
NL - Olanda 56
AT - Austria 49
BD - Bangladesh 48
AR - Argentina 45
EE - Estonia 44
CH - Svizzera 40
IQ - Iraq 35
MX - Messico 35
BE - Belgio 34
MA - Marocco 30
PL - Polonia 29
ID - Indonesia 28
PK - Pakistan 27
AU - Australia 25
SA - Arabia Saudita 21
SN - Senegal 21
EC - Ecuador 18
ZA - Sudafrica 18
ES - Italia 17
CZ - Repubblica Ceca 13
PH - Filippine 13
UZ - Uzbekistan 13
JO - Giordania 12
CL - Cile 11
CO - Colombia 11
KE - Kenya 11
PY - Paraguay 11
MY - Malesia 10
TN - Tunisia 10
HU - Ungheria 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
VE - Venezuela 8
NG - Nigeria 7
PS - Palestinian Territory 7
JM - Giamaica 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
EG - Egitto 5
OM - Oman 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AL - Albania 4
CR - Costa Rica 4
EU - Europa 4
KG - Kirghizistan 4
LT - Lituania 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PE - Perù 4
PR - Porto Rico 4
RO - Romania 4
TH - Thailandia 4
AM - Armenia 3
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
IE - Irlanda 3
IR - Iran 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
GA - Gabon 2
HR - Croazia 2
IL - Israele 2
LB - Libano 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TG - Togo 2
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
CM - Camerun 1
Totale 23.407
Città #
Ashburn 1.359
Woodbridge 1.235
Fairfield 1.102
Ann Arbor 990
Singapore 952
Houston 921
Hong Kong 871
Dallas 667
San Jose 637
Santa Clara 608
Chandler 569
Seattle 502
Cambridge 396
Wilmington 353
Sofia 337
Serra 328
Shanghai 317
Beijing 285
New York 264
Milan 251
Boardman 202
Munich 159
Princeton 152
Los Angeles 150
Ottawa 145
Izmir 140
Medford 125
Lauterbourg 122
Lawrence 120
Hefei 118
Council Bluffs 114
Ho Chi Minh City 107
Helsinki 105
Jacksonville 99
Pisa 99
Seoul 95
Florence 91
Hanoi 90
Nanjing 88
Frankfurt am Main 86
Des Moines 84
Tokyo 84
San Diego 68
London 67
Dong Ket 64
Istanbul 64
Abidjan 62
Buffalo 61
Falls Church 59
Redondo Beach 52
Columbus 49
São Paulo 47
Rome 46
Washington 42
Lucca 41
Bremen 37
Bern 35
Dearborn 35
Genoa 35
The Dalles 34
Brussels 32
Nanchang 30
Vienna 29
Nuremberg 28
Chicago 27
Rio de Janeiro 26
Shenyang 26
Casablanca 25
Phoenix 24
Boulder 23
San Francisco 23
Warsaw 23
Ogden 22
Dakar 21
Kunming 21
Amsterdam 20
Lancaster 20
Lappeenranta 20
Guangzhou 19
Hebei 19
Livorno 19
Piombino 19
Belo Horizonte 18
Changsha 18
Fuzhou 18
Pune 18
Redwood City 18
Ternay 17
Norwalk 16
Nürnberg 15
Turku 15
Da Nang 14
Detroit 14
Dhaka 14
Jüchen 14
Orem 14
Auburn Hills 13
Marseille 13
Toronto 13
Baghdad 12
Totale 17.207
Nome #
Expression status of candidate genes in mesothelioma tissues and cell lines 345
Maternal anthropometric variables and clinical factors shape neonatal microbiome 337
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 317
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 313
Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer 276
Risk of Differentiated Thyroid Carcinoma and Polymorphisms within the Susceptibility Cancer Region 8q24 253
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 246
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 246
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk 242
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma 242
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 241
Identification of miRSNPs associated with the risk of multiple myeloma 237
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 234
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma 222
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 221
MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma. 218
Inherited variants in genes somatically mutated in thyroid cancer 217
The genetic susceptibility in the development of malignant pleural mesothelioma 214
Chromosome aberrations in lymphocytes and clastogenic factors in plasma detected in Belarus children 10 years after Chernobyl accident. 212
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology 211
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. 211
Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. 209
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma 204
Bona fide targets of deregulated microRNAs in non-small cell lung cancer as tool to identify novel therapeutic targets. A review. 203
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). 202
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma 202
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium. 202
Environmental risk factors for pancreatic cancer: an update. 200
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations. 197
Benzodiazepine binding in T-lymphocytes from parkinsonian patients 196
Identificazione e caratterizzazione dei microRNA coinvolti nel Mesotelioma Pleurico Maligno 196
Characterization of novel 3'untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide 196
More targets, more pathways and more clues for mutant p53. 193
Genome-wide association study on differentiated thyroid cancer. 193
Thrombocyte phenolsulphotransferase and monoamine oxidase activity, and benzodiazepine binding in patients with dementia of Alzheimer type 191
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. 190
T-lymphocyte peripheral-type benzodiazepine binding in parkinsonian patients 187
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma 186
Comparative analysis of genetic variants in pleural fluids and solid tissue biopsies of pleural mesothelioma patients: Implications for molecular heterogeneity assessment 185
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival 185
Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium. 183
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk 182
Integrative Organelle-Based Functional Proteomics: In Silico Prediction of Impaired Functional Annotations in SACS KO Cell Model 181
Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system 181
Prediction of the biological effect of polymorphisms within microRNA binding sites. 180
The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans 180
Cytogenetic damage in lymphocytes of healthy and thyroid tumor-affected children from the Gomel region (Belarus). 179
COMPASSS (COMplex PAttern of Sequence Search Software), a simple and effective tool for mining complex motifs in whole genomes 178
MAP3K7 and GSTZ1 are associated with human longevity: a two-stage case-control study using a multilocus genotyping 178
Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 177
Genetic signature of differentiated thyroid carcinoma susceptibility: a machine learning approach 176
Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with the serum levels of the mesothelin-related protein 176
Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect 175
Correction: Inherited variants in genes somatically mutated in thyroid cancer 175
DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility 173
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism 172
Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome. 171
Chromosome aberrations in humans in relation to site of residence. 171
A Catalog of Polymorphisms Falling in MicroRNA-Binding Regions of Cancer Genes 170
Platelet phenolsulphotransferase activity in patients with dementia of Alzheimer type 168
Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review 167
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 166
Evaluation of a microarray for genotyping polymorphisms related to xenobiotic metabolism and DNA repair 163
A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA 163
A catalogue of polymorphisms related to xenobiotic metabolism and cancer susceptibility 162
Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer 162
Functional Network Profiles in ARSACS Disclosed by Aptamer-Based Proteomic Technology 162
Targeting hypoxic response for cancer therapy. 160
Obesity and the Risk of Papillary Thyroid Cancer: A Pooled Analysis of Three Case-Control Studies. 159
DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses 158
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma. 158
Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. 158
Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding. 158
Development of a yeast-based system to identify new hBRAFV600E functional interactors 157
High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA 157
A database of single-nucleotide polymorphisms and a genotyping microarray for genetic epidemiology of lung cancer 156
Platelet monoamine oxidase molecular activity in demented patients 153
Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk 153
Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan 153
Delta N133p53 Expression Levels in Relation to Haplotypes of the TP53 Internal Promoter Region 149
The importance of p53 pathway genetics in inherited and somatic cancer genomes 149
Runs of homozygosity and inbreeding in thyroid cancer 149
Sequence Variants in Cell Cycle Control Pathway, X-ray Exposure, and Lung Cancer Risk: A Multicenter Case-Control Study in Central Europe 148
Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study 148
Identification of overexpressed genes in malignant pleural mesothelioma 148
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis 146
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era. 146
Liquid biopsies from pleural effusions and plasma from patients with malignant pleural mesothelioma: A feasibility study 146
Germline genetic variability in pancreatic cancer risk and prognosis 145
Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells 144
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium. 144
Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma 144
Monoamine oxidase molecular activity in thrombocytes of demented patients 142
Systemically delivered antisense oligomers upregulate gene expression in mouse tissues 142
News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors 142
Two novel polymorphisms in 5' flanking region of the mesothelin gene are associated with soluble mesothelin-related peptide (SMRP) levels. 141
A polygenic risk score for multiple myeloma risk prediction 141
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. 140
Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach. Lancet. 2005 Oct 29-Nov 4;366(9496):1558-60 139
Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer 139
Totale 18.555
Categoria #
all - tutte 67.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021237 0 0 0 0 0 0 0 0 0 0 0 237
2021/20221.849 64 183 87 95 301 233 76 74 104 77 91 464
2022/20231.878 206 216 131 186 185 234 20 139 320 20 203 18
2023/20241.452 156 145 281 68 177 264 56 48 24 30 72 131
2024/20254.636 11 157 48 282 478 496 492 262 474 635 481 820
2025/20265.843 417 714 681 452 533 481 1.083 308 365 465 281 63
Totale 24.006